Alvi Haris, Ali Gohar, Iqbal Sadia, Ahsan Muhammad Nadeem, Siddiqui Muhammad Ali, Kirmani Tooba Ahmed, Irshad Ghazala, Baktashi Haisum, Asghar Muhammad Sohaib
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Liaquat National Hospital and Medical College, Karachi, Pakistan.
J Family Med Prim Care. 2022 Dec;11(12):7975-7978. doi: 10.4103/jfmpc.jfmpc_1336_22. Epub 2023 Jan 17.
We conducted this study on patients diagnosed with irritable bowel syndrome without identifiable stressors and replaced them with vitamin D supplements for 3 months. Almost 97 cases have repeated the vitamin D status that appeared to be sufficient, while 14 patients were missing data for follow-up. The advised option was intramuscular injection replacement but 34 out of 97 were taken oral route for replacement of Vitamin D and incidental finding is noted that serum vitamin D levels rise less in the oral group than in the intramuscular group. Mean age of our subjects was 35.97 ± 9.89 years, comprising 54% males (n = 60) and 46% females (n = 51). In the outcomes of our study, 56.7% of individuals showed complete relief from IBS symptoms after vitamin D replacement, while 36.1% reported considerable improvement. Another 6.2% had exhibited moderate relief with about 14 individuals lost to follow-up.
我们对诊断为无明显应激源的肠易激综合征患者进行了这项研究,并为他们补充维生素D,为期3个月。近97例患者的维生素D状态恢复到充足水平,而14例患者失访。建议的补充方式是肌肉注射,但97例中有34例采用口服途径补充维生素D,偶然发现口服组血清维生素D水平的升高低于肌肉注射组。我们研究对象的平均年龄为35.97±9.89岁,其中男性占54%(n = 60),女性占46%(n = 51)。在我们的研究结果中,56.7%的个体在补充维生素D后肠易激综合征症状完全缓解,而36.1%的个体报告有显著改善。另有6.2%的个体有中度缓解,约14例患者失访。